INTRODUCTIONOtitis externa is basically an inflammation on the external acoustic meatus skin, frequently associated with a secondary bacterial infection and/or fungal infection on the macerated skin of the subcutaneous tissue.1,2 It can be classified into diffuse, which is a dermatitis, when there is a reduction in wax production, epithelial scaling and edema; or localized, in this case it is a furuncle, caused by an infection in the pilosebaceous foliculum.1,2 In folk's medicine, it is common to use medicinal Brazilian plants such as arruda, macassá, barbatimão, among others, depending on the region, without however, any scientific study justifying its use. The World Health Organization advocates the use of medicinal plants, especially in public health care programs in developing countries.3,4 The plants can be used as infusion, macerated, as juice, tinctures, infiltrates or patches, for the treatment of diseases.3,5 They have many secondary metabolic pathways which will create compounds that include alkaloids, flavonoids, isoflavonoids, tannins, coumarins, glycosides, terpenes, polyacetylenes, which are specific to certain families, genera or species and that have many functions.5 Otitis externa is preferably treated topically, considering antimicrobial resistance stemming today as a risk to its therapeutic efficacy. Considering the prevalence and morbidity of this disease and the very possibility of having other means of treatment, this study aimed at assessing the in vitro antimicrobial activity of these plants' extracts and essential oils on microorganisms taken from patients with acute otitis externa.
MATERIALS AND METHODSTwenty-seven patients with clinical diagnosis of AOE (Acute Otitis Externa) without ear drum perforation nor prior use of medication,6 were selected, regardless of gender and age, during a period of three months, and we collected material from the involved ear, by using a Swab, following the standards and guidelines established for research projects involving human beings - Resolution # 196/1996 - Brazilian Ministry of Health.7 The study was approved by the ethics committee of the Lauro Wanderlei University Hospital, protocol # 341, and the patients signed an informed consent form in order to take part in the project. In order to check for antibacterial activity on the plants' extracts and essential oils, we isolated and identified the bacterial species, according to microbiology routines,8-10 and the samples were kept in agar Miller Hinton (Difco Laboratories Ltd.). From otomycosis we isolated and identified yeasts by macro and micro morphological and biochemical characteristics.11-15 The strains were kept in 2% agar Saboraud dextrose (ASD) (Difco Laboratories Ltda), stored at room temperature and at 4ºC. The extracts and essential oils used in the antimicrobial activity assays were obtained from the four plant species included on Chart 1. In order to assess antimicrobial activity, we tested the extracts in the following concentrations: 5000, 2500, 1250, 625, 313, 156 and 78µg/ml, solubilized in dimethyl-sulphoxyde-DSO, at a maximum rate of 10% and the essential oils were tested in the concentrations of 8, 4, 2, 1, 0.5 and 0.25%, according to Allegrini et al's technique. 1973.16,17
We carried out antibacterial and antifungal activities assays to determine the minimum inhibitory concentration MIC of extracts and essential oils by the diffusion in solid medium method - cavity-plate process.9,16 Control was carried out by antibiogram.
RESULTSWe observed Staphylococcus aureus in 10 cultures (37%), Pseudomonas aeruginosa in 8 cultures (29.6%), Pseudomonas aeruginosa and Staphylococcus aureus together in 5 cultures (18.5%), and Candida in 4 cultures, (14.9%), in all cases, they were associated with Gram Positive and Gram Negative Bacteria.
In the present investigation we assessed the in vitro antibacterial and antifungal activity of extracts and/or essential oils of the following medicinal plants: macassá, barbatimão, cravo-da-índia, capim-santo, camomila, hortelã da folha grossa and arruda against twelve strains of P. aeruginosa, eight strains of S. aureus, one strain of C. albicans and one strain of C. krusei.
One can see that all fungal and bacterial species investigated resisted the extract of A. suaveolens, Pithecellobium avaremotemo and Ruta graveolens.
On Table 1 we list the results of antibacterial activity for the essential oil from C. aromaticus. Pseudomonas genera was completely resistant to this essential oil in all concentrations. In the same concentration of 4% it was active against the growth of three strains of Staphylococcus and two strains of Candida. We can see that C. albicans and C. Krusei were sensitive in concentrations of up to 1%, with 10 mm in diameter inhibition halos.
The essential oil from M. chamomila did not produce inhibition on Pseudomonas; however, in the concentration of 4%, it had an inhibitory activity on the growth of three strains of Staphylococcus and two Candida strains with inhibition halos varying between 10 and 12mm in diameter (Table 2).
P. amboinicus extract in the present study proved to be active against seven of the eight copies of Staphylococcus, with inhibition halos average of 13mm in diameter; however, it was not active against P. aeruginosa and Candida ssp. (Table 3). The oil from this plant was not very effective in this study, showing action against two strains of S. aureus and C. krusei strain in the concentrations of 8 and 4% for the bacterium and 8, 4 and 2% for the fungus, these data are shown on Table 4.
The essential oil from Ruta graveolens extracts was assessed as to its antimicrobial action, because this plant has its popular use recognized in external ear pathology. The essential oil from R. graveolens at 4%, inhibited four Staphylococcus strains and all the Candida strains, with inhibition halos between 10 and 13 mm in diameter. These findings can be seen on Table 5; however, its extract did not show any activity.
DISCUSSIONOtitis externa is an infectious inflammatory process, which affects the external auditory meatus skin and usually has polymicrobial etiology.2 Hwang, Chu and Liu (2002)18 carried out a bacteriologic study in 161 patients and observed that S. aureus was as frequently found as P. aeruginosa in patients with otitis externa. These data ratify the findings of the present investigation, since there was no statistically significant difference between these bacteria. Kuczkowski et al. (2000)19, studied 55 cultures of patients with otitis externa and found a greater frequency of Staphylococcus aureus, Pseudomonas aeruginosa and Proteus mirabilis, similar to our findings; thus, we can consider that the main etiology associated with otitis externa is bacterial, and occasionally fungal.18 As far as fungi are concerned, the genus Candida was found in 4 cultures, associated with Gram-positive and Gram negative bacteria. Similar findings were reported by Ologe et al. (2002)20, when they investigated 141 patients with presumed otomycosis, they confirmed the disease in 76 (53.9%), and the fungi most frequently found were Aspergillum sp (63.4%), Candida (35.5%) and Mucor (1.3%).
Despite high technology and heavy investments from the pharmaceutical industry in the production of increasingly more potent antimicrobial drugs, microbial resistance is on the rise.21 The use of plant components with therapeutic ends has increased in Brazil. According to the World Health Organization, the use of plant components for therapeutic means has been on the rise in Brazil, and they also state that this can represent the best source of a variety of drugs.21,22 Nonetheless; these plants should not be used empirically, but rather based on controlled studies of efficacy and toxicity.
A. suaveolens - our macassá, although very much used in popular medicine for ear disorders, is not reported in the literature, both as antimicrobial drug as in terms of its analgesic and anti-inflammatory action that could justify its use, and in this study it was not efficient against the strains tested.
P. avaremotemo extract, although active against bacteria and fungi in many studies, did not prove to have any activity against external ear microorganisms.23 These findings may be associated with pathogen virulence and/or extract characteristics.
The activity of essential oils and plant extracts against bacteria and fungi is due to the presence of phyto components, which concentration may vary depending on a number of factors, such as plant growing, harvesting and also the means used to obtain the extract or the essential oil.23,24
It has been reported that essential oils are more effective against Gram positive bacteria than Gram negative, but there still is no scientific explanation for this fact.21 In the present study, the Gram negative P. aeruginosa bacteria resisted all tested oils, while the Gram positive S. aureus was sensitive to them, depending on the plant tested and its concentration.
The essential oil from C. aromaticus had an antimicrobial action against Gram positive bacteria, both in the literature studied as well as in the present investigation.23,24 We observed that the essential oil from C. citratus was not active against the bacteria and fungi used in this study; however, Araújo (2003)25 observed that this oil in the concentration of 8% was active against this fungi, but not against bacteria, as we found in this study.
The essential oil from M. chamomila inhibited the growth of Staphylococcus aureus and Bacillus subtilis and its hydro-alcoholic extract inhibited the growth of Staphylococcus aureus, Streptococcus mutans, Group B Streptococcus, Streptococcus salivarius, according to Jakovlev, 198326. In numerous papers, A M. chamomila presented antimicrobial activity, especially against P. aeruginosa27strains.
Catillo and Gonzälez (1999) observed that both the extract and the essential oil from P. amboinicus, harvested in Cuba, were active against Gram negative and Gram positive bacteria, as well as against yeasts and dermatophagoides, and the extract was more effective.28
According to Araújo (2003)25, the essential oil from R. graveolens was active against species of yeast, but not against S. aureus, similarly to the findings from Ross et al. (1980)29. However, Sá et al. (1995) noticed its activity against P. aeruginosa, S. aureus, B.subtilis25strains. These differences can be credited to the essential oil concentration and the microbial strains tested.
Further and more comprehensive studies with medicinal plants in acute otitis externa are required, especially with those plants already advocated by popular medicine. However, it is worth stressing that this is the first approach carried out in the Northeast aiming at studying if any of these plants were effective against acute otitis externa causing agents, therefore we need further studies because this is a promising therapeutic alternative, especially for the needy population.
CONCLUSIONS. aureus, P. aeruginosa and fungi of the genera Candida were the most frequently found microorganisms in the culture of patients with acute otitis external. P. aeruginosa was resistant to all tested extracts and essential oils. The essential oils from C. aromaticus and M. chamomila at 4% inhibited the growth of three S. aureus strains and of all Candida strains; such activity was seen at the concentration of 1%. The essential oil from R. graveolens at 4% inhibited Candida strains and four S. aureus strains; and the extract from P. amboinicus had inhibitory activity against seven S. aureus strains, and Candida strains were resistant. Some plants have a satisfactory effect depending on the etiological agent. We still need more comprehensive and detailed studies regarding the use of these plants, because they can represent a promising therapeutic alternative in the near future, especially in regards of the more needy population.
REFERENCES1. Hungria H. Otorrinolaringologia. 6. ed. Rio de Janeiro: Guanabara Koogan; 1991. cap. 34, p.297-301.
2. Guatimosim MHE: "Doenças da Orelha". Sociedade Brasil. ORL. Tratado de Otorrinolaringologia. 1ª ed. São Paulo, Editora Roca: 2002.p.3-20.
3. Carriconte C, Mores D, Frishtchen M Von, Cardoso Jr LE: Plantas Medicinais & Plantas alimentícias. Centro Nordestino de Medicina Popular: Universidade Federal Rural de Pernambuco, Olinda; 1995. 1:63-5.
4. Martins ER, Castro DM, Castellani DC, Dias JE. Plantas Medicinais. Viçosa, UFU: 1998. p. 220.
5. Diniz MFFM, Oliveira RAG, Malta J, Medeiros ACD. Memento Fitoterápico: As Plantas como Alternativa Terapêutica. 1. ed., João Pessoa: Editora Universitária; 1997. 1:205.
6. Goldenberg D, Golz A, Netzer A, Joachims HZ. The use of otic powder in treatment of acute external otitis. Am J Otolaryngol 2002;23(3):142-7.
7. Resolução 196/96 Do Conselho Nacional De Saúde, Comissão Nacional de Ética em pesquisa. Normas para pesquisa envolvendo seres humanos. Série Cadernos Técnicos. Ministério da Saúde, Brasília, 2000, 138p.
8. McFaddin JF. Biochemical Tests for identification of Medical Bacteria. Baltimore: William & Wilkins Co; 1980.
9. Cleeland R, Squires E. Evolution of new antimicrobials "in vitro" and experimental animal infections. In: Lorian, v. antibiotics in laboratory medicine. Baltimore: Williams C Wilkins; 1999. p.739-87.
10. Kriger Van-Rij NJW: The Years: a taxonomic study. 3 ed., Amsterdam: Elsevier Science Publishers: 1984. p. 245-270 V. 3.
11. Konemam EW, Roberts GD. Micologia: practica de laboratório, 3. ed. Buenos Aires: Medica Pan Americana: 1987; 221p.
12. McGinnis MR. Laboratory Handbook of Medical Mycology. New York: Academic Press:1980, p. 411.
13. Larone DH: Medical import fungi. 3ed. Washington: ASM Press: 1995, p. 274.
14. Casals IB. Tablet sensitivity testing of pathogenic fungi. J Clin Pathol 1979;32:719-22.
15. Hoog GS, Guarro J. Atlas of Clinical Fungi. Reus: Universitat Rovira i Virgili, 1995.
16. Bauer AW, Kirby WM, Sherris SC, Turck M. Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol 1966;45:493-6.
17. Allegrini I, Bovchberg MS, Maillols H. Émulsions d'huiles erssentielles, fabrication et applications en microbiologie. Societe de Pharmacie de Moutpellier 1973; 33(1):73-86.
18. Sander R: Otitis externa: a practical guide to treatment and prevention. Am Fam Physician 2001; 63(5):927-36, 941-2.
19. Kuczkowski J, Samet A, Brzoznowski W. Bacteriologic evaluation of otitis externa and chronic otitis media. Otolaryngol Pol 2000;54 (5):551-6.
20. Ologe FE, Nwabuisi C. Treatment outcame of otomycosis in Ilorin, Nigeria. West Afr J Med 2002;21(1):34-6.
21. Craveiro AA, Fernandes AG, Andrade CHS, Matos FJA, Alencar JW, Machado MIL. Óleo Essencial de plantas do Nordeste. Fortaleza: Ed. UFC: 1981, p. 209.
22. Cardoso HT, Santos MT. Estudos sobre a presença de antibióticos nos vegetais. Bras Med 1946;62:67-70.
23. Carlson HJ, Douglas HG, Robertson J. Antibacterial substances separated from plants. J Bacteriol 1948;55:241-8.
24. Begum J, Yusuf M, Chowdhury JU, Wahab MA. Studies on essential oils for their antibacterial and antifungal properties. Part-I: Preliminary screening of 35 essential oils. J Sci Ind Res 1993;28(4):25-34.
25. Araújo JCLV. Perfil de sensibilidade de microrganismos oportunistas de origem clínica e ambiental a óleos essenciais. 2003.77p. Tese (Mestrado em Produtos Naturais e Sintéticos Bioativos) - Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa.
26. Jakovlev V, Isaac O, Flaskamp E. Pharmacological investigation with compounds of chamazulene and matricine. Planta Méd 1983;49:67-73.
27. Matos FJA: Farmácias vivas; sistema de utilização de plantas medicinais projeto para pequenas comunidades. 2 ed. Fortaleza: EUFC: 1994: 122p.
28. Castillo RAM, González VP. Plecthranthus amboinicus (Lour.) Spreng Rev Cubana Plant Med 1999;3(3):110-5.
29. Ross SA, El-Keltawi NE, Megalla SE. Antimicrobial activity of some Egyptian aromatic plants. Fitoterapia 1980;51(2):201-6.
1 MSc, MD.
2 PhD. Head of the centro de ciências de saúde /UFPB.
3 PhD. Professor of Pharmachology - UFPB.
UFPB Laboratório de Tecnologia Farmacêutica.
Send Correspondence to: Janaina Cândida Rodrigues Nogueira - Av. Gal Bento da Gama 192 Torre João Pessoa PB 58040-090.
Paper submitted to the ABORL-CCF SGP (Management Publications System) on December 19th, 2006 and accepted for publication on September 11th, 2007. cod. 3562.
